New Current Report Filed with the SEC Disclosing Occurrence of a Triggering Event That Accelerates or Increases a Financial Obligation: 8-K – VERTEX PHARMACEUTICALS INC / MA (0000875320) (Filer)





A current report on Form 8-K was just filed with the U.S. Securities & Exchange Commission (SEC) disclosing the occurrence of an event that triggers the acceleration of or increase in a direct financial obligation or an obligation under an off-balance sheet arrangement. Details of the current report are:

8-K – VERTEX PHARMACEUTICALS INC / MA (0000875320) (Filer)
Filed: 2016-10-17 AccNo: 0000875320-16-000098 Size: 21 KB

Item 1.01: Entry into a Material Definitive Agreement

Item 1.02: Termination of a Material Definitive Agreement

Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant

Item 2.04: Triggering Events That Accelerate or Increase a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement
Filing Date: 2016-10-17T08:39:25-04:00

This is a breaking news story. You can access the complete current report through the SEC’s Edgar system: http://www.sec.gov/Archives/edgar/data/875320/000087532016000098/0000875320-16-000098-index.htm